AMENDMENT TO TERM CREDIT AGREEMENTCredit Agreement • November 7th, 2017 • Mylan N.V. • Pharmaceutical preparations • New York
AMENDMENT dated as of November 3, 2017 (this “Amendment”), to the Term Credit Agreement dated as of November 22, 2016 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among MYLAN N.V., a public limited liability company (naamloze vennootschap) incorporated and existing under the laws of the Netherlands, with its corporate seat (statutaire zetel) in Amsterdam, the Netherlands and registered with the Dutch chamber of commerce under number 61036137 (the “Borrower”), certain Affiliates and Subsidiaries of the Borrower from time to time party thereto as Guarantors, each Lender from time to time party thereto (the “Lenders”) and GOLDMAN SACHS BANK USA, as Administrative Agent (the “Agent”).
AMENDMENT TO REVOLVING CREDIT AGREEMENTCredit Agreement • November 7th, 2017 • Mylan N.V. • Pharmaceutical preparations • New York
AMENDMENT dated as of November 3, 2017 (this “Amendment”), to the Revolving Credit Agreement dated as of November 22, 2016 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among MYLAN N.V., a public limited liability company (naamloze vennootschap) incorporated and existing under the laws of the Netherlands, with its corporate seat (statutaire zetel) in Amsterdam, the Netherlands and registered with the Dutch chamber of commerce under number 61036137 (the “Borrower”), certain Affiliates and Subsidiaries of the Borrower from time to time party thereto as Guarantors, each Lender from time to time party thereto (the “Lenders”), each Issuing Bank from time to time party thereto and BANK OF AMERICA, N.A., as Administrative Agent (the “Agent”).
